Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 10, 2021

SELL
$13.38 - $18.8 $10,021 - $14,081
-749 Closed
0 $0
Q2 2021

Aug 11, 2021

SELL
$17.08 - $29.6 $426 - $740
-25 Reduced 3.23%
749 $13,000
Q4 2020

Feb 10, 2021

BUY
$2.65 - $7.61 $2,051 - $5,890
774 New
774 $5,000
Q2 2020

Aug 12, 2020

SELL
$1.04 - $1.73 $59,441 - $98,878
-57,155 Closed
0 $0
Q1 2020

May 14, 2020

BUY
$0.75 - $2.18 $42,866 - $124,597
57,155 New
57,155 $59,000

Others Institutions Holding ACRS

About Aclaris Therapeutics, Inc.


  • Ticker ACRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 66,671,800
  • Market Cap $271M
  • Description
  • Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...
More about ACRS
Track This Portfolio

Track Panagora Asset Management Inc Portfolio

Follow Panagora Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Panagora Asset Management Inc with notifications on news.